JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2022. Vol. 67. № 2
Hyperthermia in Conservative and Palliative Treatment
of Oncological Patients. Part II. Whole Body Hyperthermia
O.K. Kurpeshev1, J. Van der Zee2
1Siberian Scientific Research Institute of Hyperthermia, Novosibirsk, Russia
2Erasmus Medical Centre, Cancer Institute, Rotterdam, The Netherlands
Contact person: Orazakhmet Kurpeshev, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
CONTENTS
The analysis of the results of the use of whole-body hyperthermia (WBH) in patients with locally advanced, recurrent and / or metastatic tumors, which, as a rule, are radio- and chemo-resistant. Most patients were incurable, in connection with which the treatment was mainly carried out with a palliative purpose. The analysis showed that the method alone or in combination with chemo- and radiation therapy has pronounced direct and palliative effects, in some cases it provides long-term control. However, WBH can have side effects. This necessitates further improvement of the method, development of a set of preventive measures, as well as improvement of equipment for heating and thermometry.
AbbREVIATIONS
BrCa – Breast cancer
CE – Clinical effect
CR – complete response
CeCa – cervical cancer
CRCa – colo-rectal cancer
CT – chemotherapy
ECWBH – extracorporal WBH
HIPCT – hyperthermic intraperitoneal CT
IR – infrared radiation
IRWBH – IR whole body hyperthermia
IT – immunotherapy
LA – locally advanced
LCa – Lung cancer
LC – local control
ML – malignant limphomas
MМ – malignant mesetelioma
MSTDP – median survival time to disease progression
MST – multi-step therapy
MTS – metastases
HL – Hodgkin’s lymphoma
NSCLC – non small cell lung cancer
RT – radiation therapy
OR – objective response
OS – overall survival
OsSa – osteosarcoma
OvCa – ovarian cancer
PCa – pancreatic Cancer
PE – palliative effect
PR – partial response
RF – radiofreqency
RFWBH – radiofrequency WBH
SD – stabilization disease
SCLC – small cell lung cancer
STS – soft tissue sarcoma
TBRT – total body RT
TTD – tumor total dose
WBH – whole body hyperthermia
Keywords: general hyperthermia, palliative therapy, chemotherapy, radiation therapy, review
For citation: Kurpeshev OK, Van der Zee J. Hyperthermia in conservative and palliative treatment of oncological patients. Part ii. Whole body hyperthermia. Medical Radiology and Radiation Safety. 2022;67(2):43-58. doi: 10.33266/1024-6177-2022-67-2-43-58
References
1. Coley W.B. The Treatment of Malignant Tumors by Repeated Inoculations of Erysipelas, with a Report of Ten Original Cases. Am. J. Med. Sci. 1893;105:487-511.
2. Busch W. On the Influence Which more Violent Erysipeline Sometimes Exerts on Organized Neoplasms. Negotiations of the Natural History Association of the Prussian Rhineland and Westphalia. 1866;23:28-30 (German). [Busch W. Uber Den Einfluss, Welchen Heftigere Erysipelin Zuweilig auf Organisierte Neubildungen Ausüben // Verhandlugen des Naturhistorischen Vereines der Preussischen Rheinlande und Westphalens. 1866. No. 23. P. 28-30].
3. Ismail-zade R.S. Obshchaya Upravlyayemaya Gipertermiya v Kompleksnom Lechenii Daleko Zashedshikh i Refrakternykh Form Zlokachestvennykh Opukholey u Detey = Total Controlled Hyperthermia in the Complex Treatment of Advanced and Refractory Forms of Malignant Tumors in Children. Extended Abstract of Doctor’s thesis in Medicine. Minsk Publ., 2008.42 p. (In Russian). [Исмаил-заде Р.С. Общая управляемая гипертермия в комплексном лечении далеко зашедших и рефрактерных форм злокачественных опухолей у детей: Автореф. дис. ... докт. мед. наук. Минск, 2008. 42 с.].
4. Karev I.D., Rodina A.A., Gut N.V. Obshchaya Vysokotemperaturnaya Gipertermiya v Lechenii Disseminirovannykh Khimiorezistentnykh Opukhole = General High-Temperature Hyperthermia in the Treatment of Disseminated Chemoresistant Tumors. Materialy III Syezda Onkologov i Radiologov SNG = Materials of the III Congress of Oncologists and Radiologists of the CNG. Minsk, 25-28 May, 2004. Part 1. Minsk Publ., 2004. P. 146-149. (In Russian). [Карев И.Д., Родина А.А., Гут Н.В. Общая высокотемпературная гипертермия в лечении диссеминированных химиорезистентных опухолей // Материалы III съезда онкологов и радиологов СНГ. Минск, 25-28 мая 2004. Ч. 1. Минск, 2004. С. 146-149].
5. Mardynskiy Yu.S., Kurpeshev O.K., Pavlov V.V., Smirnova I.A. Reactions and Complications after General Electromagnetic Hyperthermia of Tumors at the “Yachta-5” Device. Rossiyskiy Onkologicheskiy Zhurnal = Russian Journal of Oncolo-
gy. 2001;6:4-8. (In Russian). [Мардынский Ю.С., Курпе-
шев О.К., Павлов В.В., Смирнова И.А. Реакции и осложнения после общей электромагнитной гипертермии опухолей на установке “Яхта-5” // Российский Онкологический журнал. 2001. № 6. С. 4-8].
6. Kurpeshev O. Radiofrequency Whole Body Hyperthermia (WBHT) in Cancer Treatment. 28th Annual Meeting Society for Thermal Medicine, New Orleans, USA. 2011. Abstract 0081. New Orleans, 2011.
7. Suvernev A.V., Ivanov G.V. Intensivnoye Teplolecheniye = Intensive Heat Therapy. Novosibirsk, Akademicheskoye Izd-vo “Geo” Publ., 2014. 106 p. (In Russian). [Сувернев А.В., Иванов Г.В. Интенсивное теплолечение. Новосибирск: Академическое изд-во “Гео”, 2014. 106 с.].
8. Van der Zee J., Faithfull N.S., van Rhoon G.C., Reinhold H.S. Whole Body Hyperthermia as a Treatment Modality. Physics and Technology of Hyperthermia. Ed. Field S.B., Franconi C. Springer, Dordrecht, 1987. P. 420-440. DOI https://doi.org/10.1007/978-94-009-3597-6.
9. Hildebrandt B., Hegewisch-Becker S., Kerner T., Nierhaus A., Bakhshandeh-Bath A., Janni W., Zumschlinge R., Sommer H., Riess H., Wust P. Current Status of Radiant Whole-Body Hyperthermia at Temperatures >41.5 o C and Practical Guidelines for the Treatment of Adults. The German ‘Interdisciplinary Working Group on Hyperthermia. Int. J. Hyperthermia. 2005;21;2:169–183. DOI: 10.1080/02656730400003401.
10. Bull J.M.C., Scott G.L., Strebel F.R., Nagle V.L., Oliver D., Redwine M., Rowe R.W., Ahn C.W., Koch S.M. Fever-Range Whole-Body Thermal Therapy Combined with Cisplatin, Gemcitabine, and Daily Interferon-Alpha: a Description of a Phase I-II Protocol. Int. J. Hyperthermia. 2008;24;8:649–662.
11. Lassche G., Crezee J., Van Herpen C.M.L. Whole-Body Hyperthermia in Combination with Systemic Therapy in Advanced Solid Malignancies. Critical Reviews in Oncology/Hematology. 2019;139:67-74. https://doi.org/10.1016/j.critrevonc.2019.04.023.
12. Robins H.I., Longo W.L., Steeves R.A. A Pilot Study of Whole Body Hyperthermia and Local Irradiation for Advanced Non-Small Cell Lung Cancer Confined TO THE Thorax. Int. J. of Rad. Oncol. Biol. Phys. 1988;15:2:427-431.
13. Robins H.I., Longo W.L., Lagoni R.K., Neville A.J., Hugander A., Schmitt C.L., Riggs C. A Phase I Trial of Lonidamine with Whole Body Hyperthermia in Advanced Cancer. Cancer Res. 1988;43:6587–6592.
14. Robins H.I., Sielaff K.M., Storer B., Hawkins M.J., Borden E.C. Phase I Trial of Human Lymphoblastoid Interferon with Whole Body Hyperthermia in Advanced Cancer. Cancer Res. 1989;49;6:1609-15.
15. Takeuchi T., Takeuchi A., Yokoyama M. Clinical Experiences of Far-Infrared Whole-Body Hyperthermia by the Use of rhd2002. Hyperthermic Oncol. 7th Proceed. Int. Congr. Abstracts. Roma. 1996;2:272-273.
16. Larkin J.M.A. Clinical Investigation of Total-Body Hyperthermia as Cancer Therapy. Cancer Research. 1979;39:2252-2254.
17. Maeta M., Koga S., Wada J., Yokoyama M., Kato N., Kawahara H., Sakai T., Hino M., Ono T., Yuasa K. Clinical Evaluation of Total-Body Hyperthermia Combined with Anticancer Chemotherapy for Far-Advanced Miscellaneous Cancer in Japan. Cancer. 1987;59;6:1101-1106. DOI: 10.1002/1097-0142(19870315)59:6<1101::aid-cncr2820
590610>3.0.co;2-g.
18. Robins H.I., Longo W.L., Steeves R.A. Cohen J.D., Schmitt C.L., Neville A.J., O’Keefe S., Lagoni R., Riggs C. Adjunctive Therapy (Whole Body Hyperthermia Versus Lonidamine) to Total Body Irradiation for the Treatment of Favorable B-Cell Neoplasms: A Report on Two Pilot Clinical Trials and Laboratory Investigations. Int. J. Radiat. Oncol. Biol. Phys. 1990;18:909–920. DOI: 10.1016/0360-3016(90)90416.
19. Bull J.M., Cronau L.H., Newman B.M., Jabboury K., Allen S.J., Ohno S., Smith T., Tonnesen A.S. Chemotherapy Resistant Sarcoma Treated with Whole Body Hyperthermia (WBH) Combined with 1-3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU). Int. J. Hyperthermia. 1992;8;3:297-304.
20. Robins H.I., Cohen J.D., Schmitt C.L., Tutsch K.D., Feierabend C., Arzoomanian R.Z., Alberti D., d’Oleire F., Longo W., Heiss C. Phase I clinical trial of carboplatin and 41.8 °C whole-body hyperthermia in cancer patients. J. Clin. Oncol. 1993;9:1787–1794. DOI: 10.1200/JCO.1993.11.9.1787. PMID: 8355046.
21. Wiedemann G.J., d’Oleire F., Erdmute K.E., Eleftheriadis S., Bucsky P., Feddersen S., Kiouche M., Geisler J., Mentzel M., Schmucker P., Feyerabend T., Weiss C., Wagner T. Ifosfamide and Carboplatin Combined with 41.8 °C Whole-Body Hyperthermia in Patients with Refractory Sarcoma and Malignant Teratoma. Cancer Research. 1994;54:5346-5350.
22. Wiedemann G.J., Robins H.I., Gutsche S., Mentzel M., Deeken M., Katschinski D.M., Eleftheriadis S., Crahe R., Weiss C., Storer B., Wagner T. Ifosfamide, Carboplatin and Etoposide (ICE) Combined with 41.8 C Whole Body Hyperthermia in Patients with Refractory Sarcoma. Eur. J. Cancer. 1996;32;5:888-892. DOI: 10.1016/0959-8049(95)00622-2.
23. Robins H.I., Rushing D., Kutz M., Tutsch K.D., Tiggelaar C.L., Paul D., Spriggs D., Kraemer C., Gillis W., Feierabend C., Arzoomanian R.Z., Longo W., Alberti D., d’Oleire F., Qu R.P., Wilding G., Stewart J.A. Phase I Clinical Trial of Melphalan and 41.8 °C Whole-Body Hyperthermia in Cancer Patients. J. Clin. Oncol. 1997;15:158–164. DOI: 10.1200/JCO.1997.15.1.158. PMID: 8996137.
24. Robins H.I., Katschinski D.M., Longo W., Grosen E., Wilding G., Gillis W., Kraemer C., Tiggelaar C.L., Rushing D., Stewart J.A., Spriggs D., Love R., Arzoomanian R.Z., Feierabend C., Alberti D., Morgan K., Simon K., d’Oleire F. A Pilot Study of Melphalan, Tumor Necrosis Factor-α and 41.8 ° C Whole-Body Hyperthermia. Cancer Chemother. Pharmacol. 1999;
43:409-414.
25. Gruber Y., Hegewisch-Becker S., Bakshandeh-Bath A., Sommer H., Hoffmann R., Hossfeld D.K. Whole-Body Hyperthermia at 41.8 °C Combined with Ifosfamide and Carboplatin in Relapsed Ovarian Carcinoma Pretreated with a Platin-Contai-
ning Regimen. Ann. Oncol. 2000;11:377.
26. Bremer K., Meyer A., Lohmann R. Pilot Study of Whole-Body Hyperthermia Combined with Chemotherapy in Patients with Metastasised Pretreated Progressive Breast, Ovarian, and Colorectal Carcinomas. Tumor Diagn. & Ther. 2001;22:115-120.
27. Westermann A.M., Grosen E.A., Katschinski D.M., Jäger D., Rietbroek R., Schink J.C., Tiggelaar C.L., Jäger E. A Pilot Study of Whole Body Hyperthermia and Carboplatin in Platinum-Resistant Ovarian Cancer. Eur. J. Cancer. 2001;37;9:1111–1117.
28. Strobl B, Janni W, Rjosk D, Rack BK, Kornya L, Bakhshandeh-Bath A, Hegewisch-Becker S, Hildebrandt B, Harald L, Sommer I. Chemotherapy with Carboplatin/Ifosfamide Combined with Whole Body Hyperthermia in Recurrent Ovarian Cancer—Results of a Phase II Study (Dolphin-1-Study). Proc. Am. Soc. Clin. Oncol. 2002;19:A2523.
29. Bakhshandeh A., Bruns I., Traynor A., Robins H.I., Eberhardt K., Demedts A., Kaukel E., Koschel G., Gatzemeier U., Kohlmann T., Dalhoff K., Ehlers E.M., Gruber Y., Zumschlinge R., Hegewisch-Becker S., Peters S.O., Wiedemann G.J. Ifosfamide, Carboplatin and Etoposide Combined with 41.8 °C Whole Body Hyperthermia for Malignant Pleural Mesothelioma. Lung Cancer. 2003;39;3:339–345.
30. Westermann A.M., Wiedemann G.J., Jager E., Jager D., Katschinski D.M., Knuthc A., Vörde sive Vörding P.Z., Van Dijk J.D.P., Finet J., Neumann A., Longo W., Bakhshandeh A., Tiggelaar C.L., Gillis W., Bailey H., Peters S.O., Robins H.I. A Systemic Hyperthermia Oncologic Working Group Trial. Ifosfamide, Carboplatin, and Etoposide Combined with 41.8 Degrees C Whole-Body Hyperthermia for Metastatic Soft Tissue Sarcoma. Oncology. 2003;64;4:312-321. DOI: 10.1159/000070287.
31. Hegewisch-Becker S., Gruber Y., Corovic A., Pichlmeier U., Atanackovic D., Nierhaus A., Hossfeld D.K. Whole Body Hyperthermia (41.8 °C) Combined with Bimonthly Oxaliplatin, High-Dose Leucovorin and 5-Fluorouracil 48-Hour Continuous Infusion in Pretreated Metastatic Colorectal Cancer: a Phase II Study. Ann. Oncol. 2002;13:1197–1204. DOI: 10.1093/annonc/mdf216.
32. Hegewisch-Becker S., Corovic A., Jaeger E.. Goekkurt J., Panse J., Nierhaus A., Hossfeld D.K., Hossfeld D.K., Pantel K. Whole Body Hyperthermia (WBH, 41.8 °C) Combined with Carboplatin and Etoposide in Advanced Biliary Tract Cancer. Proc. Am. Soc. Clin. Oncol. 2003;22:1247.
33. Douwes F., Bogovi C.J., Douwes O., Migeod F., Grote C. Whole-Body Hyperthermia in Combination with Platinum-Containing Drugs in Patients with Recurrent Ovarian Cancer. Int. J. Clin. Oncol. 2004;9;2:85-91.
34. Richel O.., Zum Vörde Sive Vörding PJ., Rietbroek R., Van der Velden J., Van Dijk J.D., Schilthuis M.S., Westermann A.M. Phase II Study of Carboplatin and Whole Body Hyperthermia (WBH) in Recurrent and Metastatic Cervical Cancer. Gynecol. Oncol. 2004;95;3:680-685.
35. Hildebrandt B., Drager J., Kerner T., Deja M., Löffel J., Stroszczynski C., Ahlers O., Felix R., Riess H., Wust P. Whole-Body Hyperthermia in the Scope of von Ardenne’s ‘Systemic Cancer Multistep Therapy (sCMT)’Combined with Chemotherapy in Patients with Metastatic Colorectal Cancer – a Phase I/II Study. Int. J. Hyperthermia. 2004;20:317–333. DOI: 10.1080/02656730310001637316.
36. Liu X.-L., Fang M.A., Zhou C.-X., Huang M., Gong H.-Y., Xie G.-Y., Hu C.-H. Therapeutic Effect of Whole-Body Hyperthermia Combined with Chemotherapy in Patients with Advanced Cancer. J. Cent South. Univ. (Med Sci). 2006;31;3:350-352.
37. Atmaca A., Al-Batran S.-E., Neumann A., Kolassa Y., Jäger D., Knuth A., Jäger E. Whole-Body Hyperthermia (WBH) in Combination with Carboplatin in Patients with Recurrent Ovarian Cancer – A Phase II Study. Gynecol. Oncol. 2009;112:384–388. DOI:10.1016/j.ygyno.2008.11.001.
38. Bakhshandeh-Bath A., Stoltz A.S., Homann N., Wagner T., Stolting S., Peters S.O. Preclinical and Clinical Aspects of Carboplatin and Gemcitabine Combined with Whole-Body Hyperthermia for Pancreatic Adenocarcinoma. Anticancer Res. 2009;29:3069-3077.
39. Zhao C., Dai C., Chen X. Whole-Body Hyperthermia Combined with Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Stage IV Advanced Gastric Cancer. Int. J. Hyperthermia. 2012;28;8:735-741. DOI:10.3109/02656736.2012.734894.
40. Douwes F.R. Local and Whole Body Hyperthermia in Chemoresistant Ovarian Cancer. Abstracts of the XXXI Conference of the International Clinical Hyperhtermia Society (ICHS). Oncothermia J. 2013;7:70-71.
41. Neumann H., Fabricius H.A., Engelhardt R. Moderate Whole-body Hyperthermia in Combination with Chemotherapy in the Treatment of Small Cell Carcinoma of the Lung: a Pilot Study. Natl. Cancer Inst. Monogr. 1982;61:427-9.42. Engelhardt R. Rationale for Clinical Application of Hyperthermia and Drugs. Strahlentherapie und Oncologie. 1987;163:428-9.
43. Engelhardt R., Muller U., Weth-Simon R., Neumann H.A., Lohr G.W. Treatment of Disseminated Malignant Melanoma with Cisplatin in Combination with Whole-Body Hyperthermia and Doxorubicin. Int. J. Hyperthermia. 1990;6;3:511-515.
44. Zhavrid E.A, Sachivko N.V, Fradkin S.Z, Rudko A.S. Total Hyperthermia in Chemoradiotherapy of Lung Cancer. Voprosy onkologii = Problems in Oncology.1991;37;9-10:962-967 (Russian). [Жаврид Э.А., Сачивко Н.В., Фрадкин С.З., Рудько А.С. Общая гипертермия при химиолучевой терапии рака легкого // Вопросы онкологии. 1991. Т.37, № 9-10. С. 962-967].
45. Rodina A.A. Obshchaya Vysokotemperaturnaya Gipertermiya v Lechenii Nekotorykh Disseminirovannykh Khimiorezistentnykh Opukholey = Total High-Temperature Hyperthermia in the Treatment of Certain Disseminated Chemoresistant Tumors. Extended Abstract of Candidate`s Thesis in Medicine. Nizhniy Novgorod Publ., 2003. 27 p. (In Russian). [Родина А.А. Общая высокотемпературная гипертермия в лечении некоторых диссеминированных химиорезистентных опухолей: Автореф. дис. … канд. мед. наук. Нижний Новгород. 2003. 27 с.].
46. Tikhonova O.A. Obshchaya Gipertermiya v Kompleksnom Lechenii Khimioradiorezistentnykh form Disseminirovannykh Opukholey Osnovnykh Lokalizatsiy = Total Hyperthermia in the Complex Treatment of Chioradio-Resistant Forms of Disseminated Tumors of the Main Localizations. Extended Abstract of Candidate`s Thesis in Medicine. Nizhniy Novgorod Publ., 2002. 22 p.
(In Russian). [Тихонова О.А. Общая гипертермия в комплексном лечении химиорадиорезистентных форм диссеминированных опухолей основных локализаций. Автореф. дис. канд. мед. наук. Нижний Новгород, 2002. 22 с.].
47. Kurpeshev O.K. Obshchaya Gipertermiya pri Disseminirovannykh i Khimiorezistentnykh Formakh Zlokachestvennykh Opukholey = Total Hyperthermia in Disseminated and Chemoresistant Forms of Malignant Tumors. Materialy II Kongressa Onkologov Uzbekistana = Materials of the II Congress of Oncologists of Uzbekistan. Tashkent Publ., 2011.
P. 261-262. (Russian). [Курпешев O.K. Общая гипертермия при диссеминированных и химиорезистентных формах злокачественных опухолей // Материалы II Конгресса онкологов Узбекистана. Ташкент, 2011. С. 261-262].
48. Levin R.D., Sanchez R., Kim Y.D., Mellijor A., Doyle M.A., Simonich W., Williams R.M. Whole Body Hyperthermia Experience in Breast Cancer at American International Hospital. Consensus on Hyperthermia for the 1990s (Edited by
H.I. Bicher et al.). New York, Plenum Press, 1990. P. 387-388.
49. Jaeger D., Atmaca A., Neumann A., Unckell J., Orth J., Jaeger E., Knuth A. 41,8 °C Whole Body Hyperthermia (WBH) Combined with Carboplatin in Patients with Advanced Ovarian Carcinoma. Annals Oncology. 2000;11;4:82.
50. Rethfeldt E., Becker M., Koldovsky P. Whole-Body Hyperthermia in the Treatment of Breast Cancer. 23rd Congress of the International Association for Breast Cancer Research. Abstract. Breast Cancer Research. 2001;3;1:A51. https://doi.org/10.1186/bcr379.
51. Zwischenberger J.B., Vertrees R.A., Bedell E.A. Percutaneous Venovenous Perfusion-Induced Systemic Hyperthermia for Lung Cancer: A Phase I Safety Study. Ann. Thorac. Surg. 2004;77;6:1916-1924; discussion 1925.
52. Xi L., Tekin D., Bhargava P., Kukreja R.C. Whole Body Hyperthermia and Preconditioning of the Heart: Basic Concepts, Complexity, and Potential Mechanisms. Int. J. Hyperthermia. 2001;17;5:439-455.
53. Robins H.I., Kalin N., Shelton S.E., Martin P.A., Shecterle L.M., Barksdale C.M., Neville A.J., Marshall J. Rise in Plasma Beta-Endorphin, ACTH, and Cortisol in Cancer Patients Undergoing Whole Body Hyperthermia. Horm. Metab. Res. 1987;19:441–443. DOI: 10.1055/s-2007-1011847.
54. Hanuscha K.-U., Janssenb C.W. The Impact of Whole-Body Hyperthermia Interventions on Mood and Depression – Are We Ready for Recommendations for Clinical Application? Int.
J. Hyperthermia. 2019;36;1:572–580. https://doi.org/10.1080/02656736.2019.1612103.
55. Locker G.J., Worel N., Bojic A., Heinrich G., Brodowicz T., Bojic A., Heinrich G., Brodowicz T., Clodi M., Funk G.-C., Knöbl P., Zielinski C.C., Köstler W.J. Whole Body Hyperthermia by Extracorporeal Circulation in Spontaneously Breathing Sarcoma Patients: Hemodynamics and Oxygen Metabolism. Int. J. Artif. Organs. 2011;34;11:1085-94. DOI: 10.5301/ijao.5000009. PMID: 22183522.
56. Grosso G., Biondi A., Marventano S., Mistretta A., Calabrese G., Basile F. Major Postoperative Complications and Survival for Colon Cancer Elderly Patients. XXV National Congress of the Italian Society of Geriatric Surgery Padova, Italy. 10-11 May 2012. BMC Surgery. 2012;12;1:S20. http://www.biomedcentral.com/1471-2482/12/S1/S20.
57. Simões C.M., Carmona M.J.C., Hajjar L.A. Vincent J.-L., Landoni G., Belletti A., Vieira J.E., de Almeida J.P., de Almeida E.P., Jr U.R., Kauling A.L., Tutyia C., Tamaoki L., Fukushima J.T., Jr. José O C.A. Predictors of Major Complications after Elective Abdominal Surgery in Cancer Patients. BMC Anesthesiology. 2018;18:49. https://doi.org/10.1186/s12871-018-0516-6.
58. Wehner H., Wey S., Meyer A. Whole Body Hyperthermia Guideline. German Society for Hyperthermia. DGHT
e.V. Version 1.0. October 2018. 2018. 20 p. (German). [Wehner H., Wey S., Meyer A. Whole-Body Hyperthermia Guideline. Deutsche Gesellschaft für Hyperthermie. DGHT e.V. Version 1.0. October 2018. 2018. 20 p.].
59. Кurpeshev OK, Van der Zee J. The Experimental Basis for the Use of Hyperthermia in Oncology. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost = Medical Radiology and Radiation Safety. 2018;63;1:57–77. DOI: 10.12737/article_5a8556b4be3e24.36808227. (In Russian). [Курпешев О.К., Ван дер Зее Я. Экспериментальные основы применения гипертермии в онкологии // Медицинская радиология и радиационная безопасность. 2018. Т.63, № 1. С. 57–77. DOI: 10.12737/article_5a8556b4be3e24.36808227].
60. Ito Y., Kobayashi Y., Yatagawa A., Matsuura Y. Effects of Whole-Body Heat Treatment on T Cell-Mediated Immune Response in Cancer Patients. The 6th Asian Congress of Hyperthermic Oncology & The 31st Japanese Congress of Thermal Medicine at Fukui City, Japan. 5-6 September. 2014;171:GSJ35.
61. Takeuchi A., Takeuchi T., Kinjo H., Kotoyori S., Shirahige M., Hasumura H. P53 Gene Therapy Combined with Whole Body Hyperthermia and Local Hyperthermia. The 6th Asian Congress of Hyperthermic Oncology & The 31st Japanese Congress of Thermal Medicine at Fukui City, Japan. 5-6 September. 2014;136:GSE43.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 30.11.2021. Accepted for publication: 30.03.2022.